Notably, Liu et al. reported that IL-6 increased the expression of DNMT1 but not DNMT3a and DNMT3b and enriched the lung cancer stem-like cell population by inhibiting the cell cycle regulator [34]. Here, DNMT3A is linked to lung carcinoma.